tradingkey.logo

Caris Life Sciences Inc

CAI

29.500USD

+1.980+7.19%
Close 07/30, 16:00ETQuotes delayed by 15 min
8.20BMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
Total revenue
--120.92M
Revenue
--120.92M
Cost of revenue
--63.85M
Operating expenses
--178.87M
R&D expenses
--23.07M
Depreciation, depletion, and amortization
--7.04M
Other operating expenses
--1.00K
Operating profit
---57.95M
Net non-operating interest income (expenses)
Non-operating interest income
--503.00K
Non-operating interest expense
--12.78M
Special income (expenses)
---32.33M
Other non-operating income (expenses)
---17.00K
Income before tax
---102.58M
Income tax
--0.00
Income after tax
---102.58M
Net income from continuous operations
---102.58M
Net income attributable to controlling interests
---127.04M
Preferred share dividend
--24.46M
Net income attributable to common shareholders
---127.04M
Basic earnings per share
---0.46
Diluted earnings per share
---0.46
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--
KeyAI